134 related articles for article (PubMed ID: 3897478)
1. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
[TBL] [Abstract][Full Text] [Related]
2. Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?
Maurice-Williams RS; Gordon YB; Sykes A
J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):175-81. PubMed ID: 7359154
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products.
Sawaya R; Sonnino V; McLaurin RL; Perrotta G
J Neurosurg; 1983 May; 58(5):699-707. PubMed ID: 6834119
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).
Fodstad H; Nilsson IM
Acta Neurochir (Wien); 1981; 56(1-2):25-38. PubMed ID: 7195642
[TBL] [Abstract][Full Text] [Related]
5. Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
Fodstad H; Pilbrant A; Schannong M; Strömberg S
Acta Neurochir (Wien); 1981; 58(1-2):1-13. PubMed ID: 7282453
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.
Tsementzis SA; Honan WP; Nightingale S; Hitchcock ER; Meyer CH
Acta Neurochir (Wien); 1990; 103(3-4):116-21. PubMed ID: 2205078
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
Schisano G; Franco A; Nina P; Papa ML; Iannuzzi M; De Biase R; Caldora M
J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
Fodstad H
J Clin Pathol Suppl (R Coll Pathol); 1980; 14():68-73. PubMed ID: 7000850
[No Abstract] [Full Text] [Related]
9. The fibrinolytic activity of cerebrospinal fluid after subarachnoid hemorrhage.
Steinmetz H; Grote E
Neurol Res; 1983; 5(4):59-65. PubMed ID: 6149487
[TBL] [Abstract][Full Text] [Related]
10. Coagulation and fibrinolytic activity of cerebrospinal fluid.
Anderson M; Matthews KB; Stuart J
J Clin Pathol; 1978 May; 31(5):488-92. PubMed ID: 649775
[TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic treatment in subarachnoid hemorrhage.
Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
Weir B; Gordon P
J Neurosurg; 1983 Feb; 58(2):242-5. PubMed ID: 6848682
[TBL] [Abstract][Full Text] [Related]
13. Haemostasis in cerebrospinal fluid. Basic concept of antifibrinolytic therapy of subarachnoid haemorrhage.
Hindersin P; Heidrich R; Endler S
Acta Neurochir Suppl (Wien); 1984; 34():1-77. PubMed ID: 6395643
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
15. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
Alvarez Garijo JA; Vilches JJ; Aznar JA
J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)].
Imanaga H; Osugi T; Kagawa M; Kita-Mura K
No Shinkei Geka; 1977 Jan; 5(1):51-8. PubMed ID: 557178
[TBL] [Abstract][Full Text] [Related]
17. Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.
Guggiari M; Dagreou F; Rivierez M; Mottet P; Gallais S; Philippon J; Viars P
Acta Neurochir (Wien); 1984; 73(1-2):25-33. PubMed ID: 6496196
[TBL] [Abstract][Full Text] [Related]
18. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
Chandra B
Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
[TBL] [Abstract][Full Text] [Related]
19. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
[TBL] [Abstract][Full Text] [Related]
20. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]